I am a medical doctor and researcher interested in immunology, stem cell transplantation, hematology and cancer.
I work with translational research associated with the development of an autologous T cell immunotherapy for solid cancer based on neoantigen technology. Currently, my team is planning a clinical first-in-human trial of our T cell product, pTTL, starting during 2022.
MD, Medical Degree 2008 at KI, Medical License 2012.
PhD at KI 2014.